Podcasts about mdt

This Podcast is sponsored by Nord VPN. Go to https://nordvpn.com/MDT and get a 30 day money back guarantee if you do not like it!0:00 Intro16:56 satelites in space getting destroyed from the sun18:00 sara thinking michelle obama is a man because she never saw her pregnant19:04 google veo ai20:04 Suga Sean UFC Fight in NY26:52 marlon got jumped28:02 mr beast having no money29:27 tinder stats on people thoughts37:02 plaque boy max new album41:35 austin and Kathryn drama53:50 Nord VPN ad55:32 its always the girls fault starting something in relationships57:04 jay cinco livestream / clip farming1:04:49 Willito brad stream1:07:19 24 hour stream at zoo and rave1:09:16 shawty bae1:11:04 10 hardest jobs1:12:06 girl leaving husband after a nose job1:13:26 top 10 easiest jobs1:16:04 dodger game vlog1:22:08 IRL Stream1:30:13 audience questions start asking us

In this episode of “One in Ten,” host Teresa Huizar speaks with Dr. Lisa Nichols, an assistant professor at the University of Northern Colorado, to discuss the challenges faced by child abuse detectives. The episode delves into the complexities and emotional toll of child sexual abuse investigations, highlighting findings from Dr. Nichols' study. Key themes include understaffing, high turnover, funding issues, the emotional impact on detectives, and communication challenges with Child Protective Services (CPS). Dr. Nichols emphasizes the need for better support and resources, including culturally competent mental health services, to improve the wellbeing and effectiveness of these law enforcement professionals.  Time Stamps: 00:00 Introduction: Detectives in Crisis 02:10 Interview with Dr. Lisa Nichols 04:00 Study Design and Methodology 06:09 Key Findings: Funding and Emotional Toll 15:13 Challenges of High Turnover 31:42 Communication Issues with CPS 39:08 Implications for Policy and Practice 42:56 Conclusion and Final Thoughts Resources:“It's Like We Never See the Light at the End of theTunnel”: Law Enforcement Perceptions on StakeholderCollaboration and Resources at CACs in a SouthernState; Journal of Child Sexual Abuse; February 2025Support the showDid you like this episode? Please leave us a review on Apple Podcasts.

In this episode we speak to the 2024 winner of the IASLT SLT Support and Mentor Award, Deirdre Kidney from St.Vincent's University Hospital. Deirdre was described as a trailblazer for SLT's in Ireland. She was nominated due to her excellent clinical skills as well as her incredible ability to provide guidance and mentorship to students, young therapists and senior SLT's - in addition to the wider MDT and medical teams.

Here is the "Small Business Showcase", which aired on Saturday, May 31st, on KRDO News Radio, from 10am to 11am MDT.

Here is the "Small Business Showcase", which aired on Saturday, May 31st, on KRDO News Radio, from 10am to 11am MDT.

Welcome to Part 4 of my 4-part series on How to Practice Mediumship! This series was designed to learn how to practice mediumship and what skills you should be working on developing in your practice readings. In this episode, we are talking about how to move past hearing the word no in a practice session. I share my 3 tips on how to work past a "no" and not let that two-letter word stop you dead in your tracks and ruin your confidence. The first tip is for beginners, the next tip is how to start to practice with the word no, and the third tip is knowing when to push past a no.  Each episode has had homework to practice each skill, so try to get in 3 practice sessions before next week's podcast episode.  This marks the end of the 4-part series- thank you for joining me, and good luck practicing your mediumship with these tips.  Book a session with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on June 7 & 8: https://www.themediuminthemiddle.com/reiki-level-one Register for the next virtual Usui Reiki Level Two Course on June 21 & 22: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on May 31 at 11 am MDT and the Space Clearing Workshop 101: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

Here is the "Small Business Showcase", which aired on Saturday, May 24th, on KRDO News Radio, from 10am to 11am MDT.

Here is the "Small Business Showcase", which aired on Saturday, May 24th, on KRDO News Radio, from 10am to 11am MDT.

This week on Dividend Talk, Derek is joined by fellow Dutch investor DazZMikey as European DGI enjoys a well-earned holiday. Together, we go on a unique “Stock Safari,” exploring dividend gems far from our usual American and Western European terrain.Along the way, they reflect on macro news, dividend hikes and cuts, and how to handle markets you don't fully trust. Hope you enjoy

This video is sponsored by Cremo. Head to Target.com for any target location to find Cremo's new line of antiperspirants and deodorants.This Podcast is sponsored by Nord VPN. Go to https://nordvpn.com/MDT and get a 30 day money back guarantee if you do not like it!This Podcast is sponsored by Huel. Go to https://huel.com/mommydaddytalk and use code: mommydaddytalk for 15% off and a free gift!0:00 intro24:05 when does the pain go away after a break up 25:49 worst breakup 27:38 content effecting routine of working out 30:52 working out now then working out back then 39:36 the conspiracy of getting a root canal 42:10 Cremo ad 44:11 AB shooting 46:32 diddy and prince 52:04 the freakoffs 54:17 NordVPN ad 55:59 sara went to EDC 1:05:30 one thing that turns you off with a guy or girl 1:12:18 you go on a date with a girl and her wallpaper is a picture of herself... 1:17:02 ginger people are black? 1:20:55 Huel ad 1:22:02 sara won in vegas / double deck blackjack 1:24:40 can money buy you happiness / love is happiness

Welcome to Part 3 of my 4-part series on How to Practice Mediumship! This series was designed to learn how to practice mediumship and what skills you should be working on developing in your practice readings. In this episode, we are talking about the flow of the messages and how to get more information to start to build the story. Being a good storyteller and having the information flow like a phone call is a skill you want to develop in mediumship. Imagine each piece of information you receive from Spirit as a lemon, and you want to juice each lemon to get as much information as possible.  Each episode has had homework to practice each skill, so try to get in 3 practice sessions before next week's podcast episode.  This is Part 3 of a 4-part series, so make sure to subscribe so you don't miss the next episodes in this journey! Book a session with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on June 7 & 8: https://www.themediuminthemiddle.com/reiki-level-one Register for the next virtual Usui Reiki Level Two Course on June 21 & 22: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on May 31 at 11 am MDT and the Space Clearing Workshop 101: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

Double Tap Episode 410 This episode of Double Tap is brought to you by: Black Rhino Concealment, Gideon Optics, RMA Defense, Night Fision, Rost Martin, and Mitchell Defense   Welcome to Double Tap, episode 410! Your hosts tonight are Jeremy Pozderac, Aaron Krieger, Nick Lynch, and me Shawn Herrin, welcome to the show! GunCon   PUBLIC EVENT - June 28th Location - Cleveland, Ohio at the Twist Drill Building (1242 E 49th St) Industry/Media Events - June 25-28 (Mixed locations around Cleveland area) https://guncon.net/event/guncon-2025/ use code wlsislife for $5 off   GOALS August 9th and 10th in Knoxville, Tennessee. https://events.goa.org/goals/   - Dear WLS Duke Of Crude - Hey fam, I'm needing some help with a build. I have a sight mark wraith 4K mini on a keltec RFB. I need to mount some kind of IR flashlight to help with night shooting on the farm. What recommendations would you have for an IR flashlight with a mount? The keltec RFB is kind of limited on rail space and the top rail is getting a little crowded with the digital optic and an offset red dot I am using for faster shooting in daytime. Mostly this rifle will be used for night time hog hunting or night time training. Thanks for your help!Duke Ballpark Frank - Dear Jeremy, When you're giving savage backshots. Do you slap the back of his head as a sign of dominance or do you mistake it for his ass? #no notes   Steven S - How do you guys adjust the retention on your BRC holsters. I received a BRC holster as a gift. The retention was a loose so I contacted them to have it adjusted. I just got it back today and the damn thing is so tight I cannot remove my gun from the holster without tapping the holster with something like a hammer. I'm a over sending it in again and I'm just trying to fix it myself. Should I heat it up in the oven and try to stretch it while it's warm?   Mike C - This question is pure curiosity. Do any of you have experience with the Primary Weapons ratchet lock castle nut and end plate, and would you buy/use it? I know it's twice as much as a regular end plate and castle nut set, but would laziness justify the additional cost? I can't wait for Jeremy's rant on how this is stupid.   Peter J - Living in commie Washington, my son turned 21 and looking at strictly range guns. What would be the most fun type of gun in your opinion for him to get? Steve B - Every now and then I get the urge to carry a revolver, as a backup or a quick run to the store gun. Seems like the Smith and Wesson 642 is a gold standard in that field but part of me likes the idea of a shrouded hammer in the Smith 638. Or am I going the wrong route altogether and should consider the Ruger LCR in 9mm over 38 special for a snub nose. Cast of WLS, what say you?   The winner of this week's swag pack is Ballpark Frank! To win your own, go to welikeshooting.com/dashboard and submit a question!   Gun Industry News Colt CBX Rifles Under Safety Recall Colt is recalling its CBX bolt-action rifles due to a safety issue. The CBX Precision and CBX Tac Hunter models may accidentally fire without pulling the trigger when safety is disengaged. Colt advises owners to stop using these rifles and return them for a refund or replacement. Retailers should also return their unsold rifles. Colt is addressing this issue directly and apologizes for any trouble. The rifles are currently being recalled. MDT Unveils Ultralight Hunting Bipods for Mountain Adventures MDT Sporting Goods launched two new bipods for mountain hunters: the Mountain Bipod (5.6 oz) and the Backcountry Bipod (5.0 oz). Both are ultra-lightweight and designed for tough terrain, using carbon fiber, aluminum, and titanium. They feature quick deployment and stability for serious hunters. Both bipods will be available starting May 16th on MDT's website. Laser Ammo's New Training Gun for Fun Practice ...

Here is the "Small Business Showcase", which aired on Saturday, May 17th, on KRDO News Radio, from 10am to 11am MDT.

Here is the "Small Business Showcase", which aired on Saturday, May 17th, on KRDO News Radio, from 10am to 11am MDT.

Critical Care St James's Hospital in the past year, have abolished the practice of measuring Gastric Residual Volumes (GRV's). This practice has been ingrained in many ICU's nationally and internationally for many years now despite little to no evidence to support it. We interview key members of the MDT today including Dr Arnaud-Felix Miailhe Consultant Intensivist, Emer O Sullivan Clinical Specialist Dietitian and Deirdre Doyle Practice Development Facilitator Critical Care St James's Hospital about the changes in practice, the literature surrounding this practice and the value of MDT involvement in driving change.

This Podcast is sponsored by Saily. Go to https://saily.com/MDT to get an exclusive 15% discount. Use Code: MDT at checkout!This Podcast is sponsored by Factor. Go to https://factormeals.com/mommydaddytalk50off and use code: mommydaddytalk50off to get 50% off plus free shipping on your first box!This video is sponsored by Cremo. Head to Target.com for any target location to find Cremo's new line of antiperspirants and deodorants.0:00 10:29 playing games when you were a kid 18:13 sara looking like the new character in GTA6 21:24 video games making people smarter 27:50 saily ad 28:50 Fireman are un loyal to girls but nurses are the worst to guys 30:26 what if their location goes off 32:01 sara and her sleep 35:30 what car should sara get? 37:29 not doing dating apps 40:45 the ryan garcia fight / suga sean 44:40 live stream in the Bahamas or tropical 46:18 Factor ad 47:34 tory lanez 52:54 calling 911 as a kid 53:35 McDonalds chicken nuggets 54:37 guilty pleasure when it comes to food 55:11 Cremo ad57:12 brads birthday 1:06:40 who would you give up for mac miller to come back

This Podcast is sponsored by Huel. Go to https://huel.com/mommydaddytalk and use code: mommydaddytalk for 15% off and a free gift!This Podcast is sponsored by Nord VPN. Go to nordvpn.com/MDT and get a 30 day money back guarantee if you do not like it!This video is sponsored by Cremo. Head to Target.com for any target location to find Cremo's new line of antiperspirants and deodorants.0:00 26:43 Just love eachother / Just be nice 27:19 brad is becoming a live streamer 28:10 release party brad went to 33:21 benny blanco cheated on Selena Gomez 37:57 $1000 trump is giving to self deport 41:25 Huel Ad 42:31 GTA6 43:13 “K” is the most triggering text you can send a person 44:35 confronting the issue or go silent? 47:38 saras deadpool shirt…. She hasn't seen it 49:10 Nord VPN Ad 50:53 sara doesn't know green day 52:30 who is winning the NBA playoffs 54:09 sara and brad vs a gorilla  1:02:00 Cremo Ad 1:04:01 the NFL draft / Sanders 1:06:27 Brads birthday

EPISODE SUMMARY: Understanding the history and challenges faced by Tribal Nations is essential for building trust and fostering meaningful partnerships within the Children's Advocacy Center (CAC) movement. In this episode, Deanna Chancellor shares insights from her experience, discussing the historical trauma Indigenous communities have faced, how it impacts engagement with service providers, and key considerations for CACs and multidisciplinary teams seeking to build trust and meaningful partnerships. Tune in to gain valuable perspectives and actionable steps for strengthening relationships with Tribal Nations. GUEST: Deanna Chancellor is a citizen of the Choctaw Nation of Oklahoma and serves as the Project Director for the Native Child Advocacy Resource Center. Prior to this she served as a Children's Advocacy Center Director for eighteen years in rural Southeastern Oklahoma. Deanna has extensive experience in the establishment and management of CAC and the coordination of the MDT. She provides training and technical assistance to Native Nations and Non-Tribal partners on issues related to the field of child maltreatment. RECOMMENDED RESOURCES: Connect with Deanna Chancellor, deanna.chancellor@mso.umt.edu Native Child Advocacy Resource Center: https://www.nativecac.org National Native Children's Trauma Center: https://www.facebook.com/NNCTC Northeast Regional Children's Advocacy Center: https://www.nrcac.org Regional Children's Advocacy Centers: https://www.regionalcacs.org   Looking for training and technical assistance for your Chapter, Children's Advocacy Center, or multidisciplinary team? Northeast Regional CAC provides training and assistance services to help you implement an effective, sustainable, collaborative response to child abuse. Visit NRCAC.org/request to learn more and request assistance today! Have an idea for a future Team Talk guest or topic? We want to hear from you! Click here to share your suggestions. Disclaimer: This project was sponsored by NRCAC from Grant Award Number 15PJDP-22-GK-03061-JJVO awarded by the Office of Juvenile Justice and Delinquency Prevention, Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the Department of Justice, OJJDP or NRCAC.

Welcome to Part 2 of my 4-part series on How to Practice Mediumship! This series was designed to learn how to practice mediumship and what skills you should be working on developing in your practice readings. In this episode, we're diving into an important foundation of mediumship: how to deliver the information you are receiving. Delivering messages clearly for your sitter is an art form!  It is difficult to be a sitter and receive information, and as the medium, it is our job to make sure the information lands.  We need to remember to pay attention to the sitter's needs, how they might be feeling, and how they understand the messages coming through. Being clear and repeating information is important during this learning process.  This is Part 2 of a 4-part series, so make sure to subscribe so you don't miss the next episodes in this journey! Book a session with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on June 7 & 8: https://www.themediuminthemiddle.com/reiki-level-one Register for the next virtual Usui Reiki Level Two Course on June 21 & 22: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on May 31 at 11 am MDT and the Space Clearing Workshop 101: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

Welcome to Part 1 of my 4-part series on How to Practice Mediumship! In this episode, we're diving into one of the most important foundations of mediumship: understanding the information you receive. As the practicing medium, it's your job to not only be the channel, but also the interpreter. That means preparing your sitter for the session, asking the right questions, and staying curious about each piece of information that comes through. We talk about how to explore details with your sitter, like asking, "Why was Grandma's purple hat significant?"—to start learning how Spirit communicates with you. I also share why practicing mediumship 2–3 times per week is essential when you're developing your abilities. It's through regular practice that patterns emerge, and those patterns are the key to building your confidence and accuracy as a medium. This is Part 1 of a 4-part series, so make sure to subscribe so you don't miss the next episodes in this journey! Join the Advanced Reiki Practitioner Masterclass on May 3 at 11 am MDT, for continued education after your Reiki Level Two course. More information here: https://www.themediuminthemiddle.com/reiki-advanced Book a session with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on May 10 & 11: https://www.themediuminthemiddle.com/reiki-level-one Register for the next virtual Usui Reiki Level Two Course on May 24 & 25: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on May 31 at 11 am MDT and the Space Clearing Workshop 101: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

I went to see an illusionist, and it completely blew my mind. I had to share it with you! I was so amazed, I walked out of the first show and immediately bought tickets for the next night's show. It was that good!  In this episode, I'm recapping the wild, magical, and mind-reading madness that had me (and the whole audience) questioning reality. From sleight of hand to straight-up telepathy, this illusionist delivered a show that had me wondering: Is this magic… or something more? I also dive into what 25 years of mastering a craft really looks like — the detail, the discipline, and the showmanship. If you love a little mystery, a lot of awe, and the thrill of being totally fooled in the best way, this one's for you. I highly recommend seeing this kind of show at least once in your life. Just be prepared to pick your jaw up off the floor. Join the Advanced Reiki Practitioner Masterclass on May 3 at 11 am MDT, for continued education after your Reiki Level Two course. More information here: https://www.themediuminthemiddle.com/reiki-advanced Book a session with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on May 10 & 11: https://www.themediuminthemiddle.com/reiki-level-one Register for the next virtual Usui Reiki Level Two Course on May 24 & 25: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on May 31 at 11 am MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

Send us a textJess and Karli can't believe it's been one whole year of Taylor Swift's The Tortured Poets Department! Today the girls are walking down memory lane and discussing their thoughts on the album now that they've had a chance to really sit with it and listen for a full year. From overall thoughts on the album, to discussing the prologue written by Stevie Nicks and the “In Summation” written by Taylor Swift herself, to answering some rapid fire questions, it will be an episode you won't want to miss.Plus Karli found some Taylor Swift survey's that share more about swifties overall thoughts on TTPD, including favorite initial songs and favorite songs now. They round out the episode by creating their own Tortured Poets Department standard edition by choosing their top 16 favorite songs off the Anthology.Text us what songs they left off their standard editions that you would definitely keep on your own version!Don't forget to join our Patreon to participate in our next Taylor Swift trivia night on April 23 at 7:30 MDT // https://www.patreon.com/TypicalTuesdayNightPodcastSPONSORS:GOOSEBUMPS (TTN15)FAZIT (TTN15)The Tortured Poets Department || Taylor Swift Albums || TTPD || Swifties || Taylor Swift PodcastSupport the showFollow along to hear a new Taylor Swift related episode every single Tuesday.Watch our episodes on YouTube!Follow Us On Social Media:Typical Tuesday Night Podcast @typicaltuesdaynight.podcastKarli @everyday_ellisJess @jess.taitJoin our Patreon for bonus episodes and exclusive Taylor Swift group chat!Shop Our Merch!Feel free to contact us at typicaltuesdaynightpodcast@gmail.com

Imagine doing some of the most emotionally challenging work in the world, with a team by your side, offering constant, sometimes invisible support. In this episode, we explore the vital relationship between Children's Advocacy Center (CAC) staff and their multidisciplinary team (MDT) partners—teams that don't just work together but lean on each other in unseen ways. Joined by Lydia Crivens, Christine Woods, and Johnny Vallejo, we discuss how collaboration, shared values, and everyday acts of appreciation help sustain these teams through the most difficult cases. Discover why strong teamwork is essential in the field of child protection and how it shapes lasting impact for children and families.  Download Transcript  Guests:   Lydia O. Crivens  Deputy Director  Memphis Child Advocacy Center    Johnny Vallejo  Multi-Disciplinary Team (MDT) Coordinator, Volunteer and Intern Manager  The Children's Advocacy Center – Covina (Main Campus) & Los Alamitos (Satellite Site)    Christine Wood, BA  Former Lead MDT Coordinator    Barren River Area Child Advocacy Center         Show Notes:  In this episode of The SRCAC Exchange, host Christina Rouse leads a powerful discussion on the importance of teamwork and supportive relationships within the Children's Advocacy Center (CAC) network. This season centers on the "invisible threads" that strengthen the dedication and resilience of professionals working in child abuse prevention. Christina is joined by guests Lydia Crivens, Christine Wood, and Johnny Vallejo, who are all deeply involved in the CAC movement and share insights into creating a supportive and connected work environment. They explore topics such as the value of multidisciplinary team (MDT) partnerships, fostering resilience, and building trust through natural interactions, which together contribute to the sustainability of this challenging yet essential work.  Throughout the conversation, each guest shares inspiring stories that highlight the collaborative power of CACs. They discuss examples of their teams coming together in difficult cases, the ways they build rapport and support among MDT members, and the small yet impactful gestures, like shoutouts and awards, that reinforce team cohesion and individual motivation. The episode closes with a reflection on how collective strength and unity are central to the CAC mission, and that teamwork is key to creating positive outcomes for children and families. Hit the subscribe button now!     Key Quotes:  "When you see someone and you talk with them regularly, you trust their perspective because you know them a bit more than someone you hadn't reached out to."- Lydia Crivens  "When you get to hear words of encouragement from your team, it just reassures you that you're doing this work and that others see it, which pushes you forward." -Christine Wood  "Coming to the CAC is actually a really nice experience for our partners because they know they're in good company and working with a team that genuinely cares."- Johnny Vallejo    Resources:   “Team Functioning and Performance in Child Advocacy Center Multidisciplinary Teams,” McGuier, E. A.; Rothenberger, S. D.; Campbell, K. A.; Keeshin, B.; Weingart, L. R.; & Kolko, D. J. (2022) [Article]    Host:   Christina Rouse, MSW  Program Manager, CAC Development  Southern Regional CAC    Project Manager:  Lauren Tanner, MSEd  Program Manager, Communications & Instructional Design  Southern Regional CAC    Want to hear more? Subscribe to The SRCAC Exchange to be sure you don't miss an episode!   Like what you hear? Show your support by leaving a rating and review for The SRCAC Exchange podcast.   Connect with us by  Visiting our website  Signing up for our emails  Following us on Facebook & LinkedIn  Contacting us  Connect with your Chapter  Midwest Region Chapters  Northeast Region Chapters  Southern Region Chapters  Western Region Chapters  Connect to your Regional CAC  National Children's Advocacy Center  Peachtree Sound    Sponsor:  Office of Juvenile Justice and Delinquency Prevention    Resources:  CE-CERT Training [Training]  Reset. Reflect. Refuel. Hub [Video Series]   Psychological First Aid Guide for Children's Advocacy Center Supervisors [Resource] 

  Welcome to the Firearms Insider Gun & Gear Review Podcast episode 572. This episode is brought to you by Walker Defense, Primary Arms, and XS Sights. In this show I have a bullpup kit review. We talk about the Judge XL, a carbon fiber holster, and MDT's new LSS gen 3 chassis builder   As […] The post Gun & Gear Review 572 – Not an AR Bullpup appeared first on Firearms Radio Network.

  Welcome to the Firearms Insider Gun & Gear Review Podcast episode 572. This episode is brought to you by Walker Defense, Primary Arms, and XS Sights. In this show I have a bullpup kit review. We talk about the Judge XL, a carbon fiber holster, and MDT's new LSS gen 3 chassis builder   As you may know, we showcase guns, gear, and anything else you might be interested in. We do our best to evaluate products from an unbiased and honest perspective.   I'm Chad Wallace, host of the most dedicated firearms podcast around With me tonight are: Rob, Rusty, Tony   Sponsor #1: Walker Defense Research   Walker Defense provides shooters with the finest, most innovative, quality, tactical accessories and firearm components around. From their NILE grip panels to their NERO muzzle brakes, no details are ever left behind. Only top quality materials are used in the manufacturing process. Together, all of this gives you some of the best firearm performance around. Everything they have to offer is proudly made in the USA. Walker Defense, where American ingenuity meets bleeding edge technology.   Our Walker Defense Product of the week is - Titanium BCG   Use code “INSIDER15” FOR 15% OFF everything at walkerdr.com   What we did in Firearms:   Announcements: Bandwidth sponsor Patriot Patch Co.  And their Patch of the Month Club! T-shirts are available through our FRN site, or click the “Merch” tab on Firearmsinsider.tv   AFFILIATES / DISCOUNTS: Walker Defense Research - enter “INSIDER15” for 15% off XS Sights - “GGR20” for 20% off Primary Arms VZ Grips - “GGR15” for 15% off handgun and rifle grips Brownells Gun Guys Garage discount code - “FRN15OFF” LA Police Gear Atibal Optics - enter “FIREARMSINSIDER20” for 20% off 5.11 Tactical PowerTac Lights - enter “GGR” for a real good discount JSD Supply Modern Spartan Systems - “GGR15” for 15% off Rough Cut Holsters - “firearmsinsider” for 20% off Global Ordnance Infinite Defense (Infinity Targets) - “PEW15” for 15% off Guns.com Magpul Palmetto State Armory Unique ARs - “GunGearReview” for 10% off CobraTec Knives - “GGR10” for 10% off Nutrient Survival - “GGR10” for 10% off Gideon Optics - “GGR” or “INSIDER” for 10% off Lone Wolf Arms US Optics - “INSIDER15” for 15% off Camorado - “FIREARMSINSIDER” for 5% off Optics Planet Midway USA   ROB - Disclaimer The views and opinions expressed in this podcast are those of the individual co-hosts and do not reflect the official policy or position of the Firearms Radio Network and/or their employers. This is NOT legal advice, nor should it be considered as such. Viewer discretion is advised. This is especially true on live shows.   Main Topic is sponsored by: Primary Arms     Primary Arms seeks to provide the best shopping experience for everything firearms. They have a smorgasbord of products from your favorite manufacturers, including a complete selection of rifles, handguns, firearm parts, ammunition, and shooting gear.   Are you also looking for optics that deliver unbeatable quality without breaking the bank? Primary Arms Optics has you covered with everything from inexpensive red dots, to top tier magnified optics. Everything Primary Arms carries comes with a commitment to superior service, quality products, and an expert support team.    Our Primary Arms product of the week is - Radian Raptor AR10/SR25 charging handle   Find everything you need by heading over to PrimaryArms.com   Main Topic: Product Review             Chad - SRU bullpup chassis    Product Spotlight and Discussion:    Gideon Judge XL Code “GGR” for 10% off MSRP - $269.99   Falco AX91 carbon fiber  MSRP - $299.95   MDT LSS Gen 3 Build your own https://mdttac.com/us/lss-gen3-landing-page  MSRP - $459.90 and up, average around $1000  

Please join us! Enrollment for Leveled-Up is currently open but closes this Friday, April 25 at 11:59 pm MDT. You shouldn't have to settle for less in your executive assistant role. Leveled-up is for you if you want a roadmap to take your career to the next level. Here's the link to learn more. Here's the link to a template requesting employer sponsorship.

In this episode, I'm sharing a heartfelt story about a father in Spirit who was determined to deliver a Valentine's Day bouquet — and how I found myself buying flowers for a friend on his behalf. We've all had those moments where we wonder: “Is this really Spirit? Or am I just making it up?” In this episode, I unpack that exact feeling, the persistence Spirit can show when they have a message to share, and the beautiful way this dad made sure his love was felt from the other side. This story is a reminder that signs, nudges, and intuitive hits are rarely random — and Spirit has its ways of making sure the message gets through.   Join the Advanced Reiki Practitioner Masterclass for continued education after your Reiki Level Two course, more information here: https://www.themediuminthemiddle.com/reiki-advanced Book a session with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on May 10 & 11: https://www.themediuminthemiddle.com/reiki-level-one Register for the next virtual Usui Reiki Level Two Course on April 26 & 27: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on April 19 at 11 am MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

In this small but powerful episode, we dive back into the world of mediumship and the remarkable ways spirit communicates with us to sneak messages in. I share a heartfelt and moving example from an Akashic Record reading that shows how even the smallest moments are deeply significant. What seemed like a random example during the session turned out to be a profound message from a mother's son, who had passed. Spirit's subtle guidance proved that no moment is ever truly random when it comes to healing, connection, and love.  Join me as I walk through this incredible experience and discuss how Spirit works behind the scenes to deliver the messages we need, even when we least expect it. No example is ever random!  Join the Advanced Reiki Practitioner Masterclass for continued education after your Reiki Level Two course, more information here: https://www.themediuminthemiddle.com/reiki-advanced Book a session with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on May 10 & 11: https://www.themediuminthemiddle.com/reiki-level-one Register for the next virtual Usui Reiki Level Two Course on April 26 & 27: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on April 19 at 11 am MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

Send us a textI'd expected this to be an AI free show but, let's face it, that just isn't likely in 2025 but the good news is that in the show Pete Major,  vice president of fintech services at CUSO MDT, offers concrete AI use cases at work in MDT and he also, importantly, offers cautions about security and the leading AI tools.In a rush to stay abreast of the fast moving AI universe are some credit unions losing sight of the need to be very sure of the security of the tools they use? Maybe.Major provides tips on how to stay secure while still using AI tools..But there's a lot more in this show.We talk for instance about the need of CUs to keep security in mind when using any technology tools.  If there are flaws - and there have been some doozies in recent years - it's the credit union that will be saddled with the bulk of the blame.On a happier note Major discusses a suite of tools for small business members at credit unions - and, he says, demand for the tools is very hot.  Is offering good tools a path to winning more business members? Just maybe.We close the show pondering what the developments in Washington DC - anything from an end to credit union tax exemption to an end to NCUA - might mean for credit unions and also the rising CU interest in merging.There's a lot to unpack in this show.  Listen up.Like what you are hearing? Find out how you can help sponsor this podcast here. Very affordable sponsorship packages are available. Email rjmcgarvey@gmail.com  And like this podcast on whatever service you use to stream it. That matters.  Find out more about CU2.0 and the digital transformation of credit unions here. It's a journey every credit union needs to take. Pronto

Ray Cotolo along with In The Money's Mike Pribozie as well as Century Downs' Murray Slough take a look at the $3,800-plus carryover for the Pick 5 at Century Downs on Saturday afternoon (April 5)! The sequence covers Races 1 through 5 and is slated to go postward at 12:45 p.m. (MDT).The three also take a look at the Late Pick 4 Sequence at Fraser Downs, which covers Races 5 through 8, on its card of racing for Friday night (April 4).

EPISODE SUMMARY: School Resource Officers (SROs) play a vital role in Children's Advocacy Centers (CACs) and multidisciplinary teams (MDTs). In this episode, we explore the importance of collaboration between SROs and CACs in the multidisciplinary response to child abuse cases, along with strategies for overcoming common challenges. Whether you're looking to strengthen an existing partnership or establish a new one, tune in for valuable insights and practical advice. Topics in this episode: Understanding the roles (4:13) Overlapping of roles (7:55) Building and maintaining the CAC and SRO partnership (11:41) Role of the school district Barriers and challenges Shared understanding Value of SROs as MDT partners (24:11) SRO training (28:03) Advice for CAC/MDT interested in forming a relationship with SROs (32:53)   GUESTS: Amy- Lynn Sullivan, Program Coordinator/Forensic Interviewer at Child Advocacy Center of Hillsborough County-North Detective Kyler Stevenson, Manchester New Hampshire Police Department Jennifer Shumway, CSEC Coordinator at Cumberland County Children's Advocacy Center  Officer Timothy Dalton, Scarborough Police Department Lauren Dembski-Martin, Social Services Manager at Scarborough Police Department   RECOMMENDED RESOURCES: Cumberland County Children's Advocacy Center: https://cumberlandcountycac.org KNOW & TELL: https://knowandtell.org Child Abuse: The KNOW & Tell Program (NCJTC): https://ncjtc.fvtc.edu/trainings/TR00008379/TRI2406800/child-abuse-the-know-tell-program Northeast Regional Children's Advocacy Center: https://www.nrcac.org Regional Children's Advocacy Centers: https://www.regionalcacs.org   Have an idea for a future Team Talk guest or topic? We want to hear from you! Click here to share your suggestions. Disclaimer: This project was sponsored by NRCAC from Grant Award Number 15PJDP-22-GK-03061-JJVO awarded by the Office of Juvenile Justice and Delinquency Prevention, Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the Department of Justice, OJJDP or NRCAC.

In this episode, I'm diving into why patience plays such a crucial role in when you decide to have a mediumship reading after a loved one passes. As a medium with years of experience in this field, I am sharing my recommendations on why you might want to wait before scheduling a reading—and how long you should wait for the most impactful and healing experience. If you've recently lost a loved one or are feeling the urge to connect with the other side, it's natural to want to jump right into a reading. But from my experience, there's power in waiting and in this episode I share why. Grief is a deeply personal journey, and timing matters when it comes to mediumship.  Tune in to learn more about why patience is your ally when it comes to mediumship readings! If you enjoyed today's episode, please leave a review and share it with someone who might benefit from hearing this! Your support helps the podcast grow and reach more people who are looking for guidance on their spiritual journey.  Book with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on April 12 & 13 (3 spots left!): https://www.themediuminthemiddle.com/reiki-level-one Register for the Usui Reiki Level Two Course on April 26 & 27: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on April 19 at 11 am MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

In this episode, I'm diving into the questions you've been asking about connecting with spirit and mediumship! A huge thank you to everyone who participated in my Instagram poll—your curiosity and passion for the spirit world inspired some truly fascinating questions. Your questions have been answered! Am I, and why am I gifted? How do you learn to connect and understand messages? After not connecting for months, how do I get back into the groove? If you dream of a passed loved one, is there always a message? How do you keep your energy strong while doing energy work? Simple practices to connect with spirit?  How do you quiet your mind? How do you connect to someone who has passed vs. spirit guides?  Tune in for all the answers and more!  Mentees in the Middle Spring cohort for one-on-one mentorship. Only 4 spots left! https://www.themediuminthemiddle.com/mentorship Book with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on April 12 & 13: https://www.themediuminthemiddle.com/reiki-level-one Register for the Usui Reiki Level Two Course on April 26 & 27: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on March 27 from 6:00 pm to 7:15 pm MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

BYU basketball defeated the VCU Rams 80-71 in the First-Round of the 2025 NCAA Tournament in Denver, Colorado. KSL Sports BYU Insider Mitch Harper shared his thoughts from BYU's first NCAA win since 2012, and first Round of 64 victory since 2011. Also, Mitch looks at the Wisconsin Badgers as BYU gets set to take on the Badgers on CBS on Saturday at 5:45 p.m. (MDT). Subscribe to the Cougar Tracks Podcast! Apple: https://podcasts.apple.com/us/podcast/cougar-tracks/id1146971609 YouTube Podcast: https://kslsports.com/category/podcast_results/?sid=2035&n=Cougar%20Tracks Download the KSL Sports app Google: https://play.google.com/store/apps/details?id=com.bonneville.kslsports&hl=en_US iOS: https://apps.apple.com/us/app/ksl-sports/id1435930251

In this episode, I share how I ended up as a sitter in a mediumship practice circle who was meant to be receiving readings but ended up reading my partners! Spirit works in mysterious ways. I had just finished work, saw a request on Facebook for a sitter, knew I would be selected, joined the group and then ended up giving two people amazing messages from their loved ones. This experience also left me with a "you go Medium in the Middle!!" experience, as the information I brought through was so specific! A fun experience for me, a teacher, to end up in a mediumship practice circle! Tune in to hear how amazing Spirit was in this super fun mediumship experience.  Mentees in the Middle, Spring cohort for one-on-one mentorship: https://www.themediuminthemiddle.com/mentorship Book with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on April 12 & 13: https://www.themediuminthemiddle.com/reiki-level-one Register for the Usui Reiki Level Two Course on April 26 & 27: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on March 27 from 6:00 pm to 7:15 pm MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

Got Health Questions or Comments?

This episode was inspired by a question from one of my Reiki students. While we were learning to clear our energy in the Reiki Level One course, they asked "Has there ever been anyone's energy you don't want to clear?" This brought up a great conversation about energy, is energy good or bad, do we need to clear energy, how often we should clear our energy and more. This episode discusses this question and reminds you that your boundaries and energetic clearing practices are based on your own comfort levels! You get to decide what energies you keep on you and what you need to clear. Tune in for a great discussion on energy and clearing energy!  Book with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on April 12 & 13: https://www.themediuminthemiddle.com/reiki-level-one Register for the Usui Reiki Level Two Course April 26 & 27: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on March 15 from  11:00 am to 12:15 pm MDT and March 27 from 6:00 pm to 7:15 pm MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

In this episode, we dive deep into the connection between your body and intuition. We explore how to tune in and truly listen to the signals your body is sending you—whether it's a physical ache, emotional shift, or subtle nudge. I'll share my personal "24-Hour Rule" for how long you have to respond to your body's messages before they escalate, and how you can use this timeframe to make powerful, mindful changes in your life. But here's the question: what's YOUR rule? Join me as we discuss how you can learn to honour and trust your body's wisdom and use it as a guide to make healthier, more intentional decisions and changes. Ultimately, I want to make your life easier and faster by learning about what your body is trying to tell you.  Tune in to discover how to develop your own intuition and find your personal rhythm in response to your body's warning signs! Also, celebrating in this episode hitting 200 virtual Reiki trainings!! Book with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on April 12 & 13: https://www.themediuminthemiddle.com/reiki-level-one Register for the Usui Reiki Level Two Course, March 8 & 9 (1 spot left!) and April 26 & 27: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on March 15 at  11:00 am to 12:15 pm MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

Dr. Neeraj Agarwal and Dr. Peter Hoskin discuss key abstracts in GU cancers from the 2025 ASCO Genitourinary Cancers Symposium, including novel therapies in prostate, bladder, and kidney cancer and the impact of combination therapies on patient outcomes. TRANSCSRIPT Dr. Neeraj Agarwal: Hello, and welcome to the ASCO Daily News Podcast. I'm Dr. Neeraj Agarwal, the director of the Genitourinary Oncology Program and professor of medicine at the Huntsman Cancer Institute at the University of Utah, and editor-in-chief of ASCO Daily News. Today, we'll be discussing practice-informing abstracts and other key advances in GU oncology featured at the 2025 ASCO Genitourinary Cancers Symposium. Joining me for this discussion is Dr. Peter Hoskin, the chair of this year's ASCO GU Symposium. Dr. Hoskin is a professor in clinical oncology in the University of Manchester and honorary consultant in clinical oncology at the Christie Hospital, Manchester, and University College Hospital London, in the United Kingdom. Our full disclosures are available in the transcript of this episode. Peter, thank you for joining us today. Dr. Peter Hoskin: Thank you so much, Neeraj. I am very pleased to be here. Dr. Neeraj Agarwal: The GU meeting highlighted remarkable advancements across the spectrum of GU malignancies. What stood out to you as the most exciting developments at the ASCO GU Symposium?  Dr. Peter Hoskin: The theme of this year's meeting was "Driving Innovation, Improving Patient Care," and this reflected ASCO GU's incredible milestone in GU cancer research over the years. We were thrilled to welcome almost 6,000 attendees on this occasion from over 70 countries, and most of them were attending in person and not online, although this was a hybrid meeting. Furthermore, we had more than 1,000 abstract submissions. You can imagine then that it fostered fantastic networking opportunities and facilitated valuable knowledge and idea exchanges among experts, trainees, and mentees. So, to start I'd like to come back to you for a second because the first day started with a focus on prostate cancer and some of the key clinical trials. And congratulations to you, Neeraj, on sharing the data from the TALAPRO-2 trial, which we were eagerly awaiting. I'd love to get your thoughts on the data that you presented. Could you tell us more about that trial, Abstract LBA18?  Dr. Neeraj Agarwal: Yes, Peter, I agree with you. It was such an exciting conference overall and thank you for your leadership of this conference. So, let's talk about the TALAPRO-2 trial. First of all, I would like to remind our audience that the combination of talazoparib plus enzalutamide was approved by the U.S. FDA in June 2023 in patients with metastatic castration-resistant prostate cancer harboring HRR gene alterations, after this combination improved the primary endpoint of radiographic progression-free survival compared to enzalutamide alone in the randomized, double-blind, placebo-controlled, multi-cohort phase 3 TALAPRO-2 trial. In the abstract I presented at ASCO GU 2025, we reported the final overall survival data, which was a key alpha-protected secondary endpoint in cohort 1, which enrolled an all-comer population of patients with mCRPC. So, at a median follow-up of around 53 months, in the intention-to-treat population, the combination of talazoparib plus enzalutamide significantly reduced the risk of death by 20% compared to enzalutamide alone, with a median OS of 45.8 months in the experimental arm versus 37 months in the control arm, which was an active control arm of enzalutamide. This improvement was consistent in patients with HRR alterations with a hazard ratio of 0.54 and in those with non-deficient or unknown HRR status, with a hazard ratio of 0.87. In a post hoc analysis, the hazard ratio for OS was 0.78 favoring the combination in those patients who did not have any HRR gene alteration in their tumors by both tissue and ctDNA testing. Consistent with the primary analysis, the updated rPFS data also favored the experimental arm with a median rPFS of 33.1 compared to 19.5 months in the control arm, and a hazard ratio of 0.667. No new safety signals were identified with extended follow-up. Thus, TALAPRO-2 is the first PARP inhibitor plus ARPI study to show a statistically significant and a clinically meaningful improvement in OS compared to standard-of-care enzalutamide as first-line treatment in patients with mCRPC unselected for HRR gene alterations. Dr. Peter Hoskin: Thank you, Neeraj. That's a great summary of the data presented and very important data indeed. There was another abstract also featured in the same session, Abstract 20, titled “Which patients with metastatic hormone-sensitive prostate cancer benefit more from androgen receptor pathway inhibitors? STOPCAP meta-analyses of individual participant data.” Neeraj, could you tell us more about this abstract? Dr. Neeraj Agarwal: Absolutely, I would be delighted to. So, in this meta-analysis, Dr. David Fischer and colleagues pooled individual participant data from different randomized phase 3 trials in the mHSPC setting to assess the potential ARPI effect modifiers and determine who benefits more from an ARPI plus ADT doublet. The primary outcome was OS for main effects and PFS for subgroup analyses. Prostate cancer specific survival was a sensitivity outcome. The investigators pooled data from 11 ARPI trials and more than 11,000 patients. Overall, there was a clear benefit of adding an ARPI on both OS and PFS, with hazard ratios of 0.66 and 0.51, respectively, representing a 13% and 21% absolute improvement at 5 years, respectively, with no clear difference by the class of agent. When stratifying the patients by age group, the effects of adding an ARPI on OS and PFS were slightly smaller in patients older than 75, than in those younger than 65, or aged between 65 and 75 years. Notably, in the trials assessing the use of abiraterone, we saw very little OS effects in the group of patients older than 75, however there was some benefit maintained in prostate-cancer specific survival, suggesting that other causes of death may be having an impact. The effects of the other ARPIs, or ‘lutamides' as I would call them, were similar across all three age subgroups on both OS and PFS. Therefore, the majority of patients with mHSPC benefit from the addition of ARPIs, and the benefits/risks of abiraterone and other ‘amides' must be considered in older patients.  Dr. Peter Hoskin: Thanks, Neeraj. Another great summary relevant to our day-to-day practice. Of course, there's ongoing collection of individual patient data from other key trials, which will allow robust comparison of ARPI doublet with triplet therapy (including docetaxel), guiding more personalized treatment.   Dr. Neeraj Agarwal: I agree with you, Peter, we need more data to help guide personalized treatment for patients with mHSPC and potentially guide de-escalation versus escalation strategies. Now, moving on to a different setting in prostate cancer, would you like to mention Abstract 17 titled, “Overall survival and quality of life with Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in poor-risk, metastatic, castration-resistant prostate cancer in ENZA-p (ANZUP 1901),” presented by Dr. Louise Emmett? Dr. Peter Hoskin: Of course I will. So, ENZA-p was a multicenter, open-label, randomized, phase 2 trial conducted in Australia. It randomized 163 patients into adaptive doses (2 or 4 cycles) of Lu-PSMA-617 plus enzalutamide versus enzalutamide alone as first-line treatment in PSMA-PET-CT-positive, poor-risk, mCRPC. The interim analysis of ENZA-p with median follow-up 20 months showed improved PSA-progression-free survival with the addition of Lu-PSMA-617 to enzalutamide. Here, the investigators reported the secondary outcomes, overall survival, and health-related quality of life (HRQOL). After a median follow up of 34 months, overall survival was longer in the combination arm compared to the enzalutamide arm, with a median OS of 34 months compared to 26 months; with an HR of 0.55. Moreover, the combination improved both deterioration-free survival and health-related quality of life indicators for pain, fatigue, physical function, and overall health and quality of life compared to the control arm. Consistent with the primary analysis, the rPFS also favored the experimental arm with a median rPFS of 17 months compared to 14 months with a HR of 0.61. So, the addition of LuPSMA improved overall survival, and HRQOL in patients with high-risk mCRPC. Dr. Neeraj Agarwal: Thank you, Peter. Great summary, and promising results with Lu-177 and ARPI combination in first line treatment for mCRPC among patients who had two or more high risk features associated with early enzalutamide failure. Before we move on to bladder cancer, would you like to tell us about Abstract 15 titled, “World-wide oligometastatic prostate cancer (omPC) meta-analysis leveraging individual patient data (IPD) from randomized trials (WOLVERINE): An analysis from the X-MET collaboration,” presented by Dr. Chad Tang?  Dr. Peter Hoskin: Sure. So, with metastatic-directed therapy (MDT), we have a number of phase 2 studies making up the database, and the X-MET collaboration aimed to consolidate all randomized data on oligometastatic solid tumors. This abstract presented pooled individual patient data from all the published trials involving patients with oligometastatic prostate cancer who received MDT alongside standard of care (SOC) against SOC alone. The analysis included data from five trials, encompassing 472 patients with oligometastatic prostate cancer, and followed for a median of 41 months. Patients were randomly assigned in a 1:1 ratio to receive either MDT plus SOC or SOC alone. The addition of MDT significantly improved PFS. The median PFS was 32 months with MDT compared to 14.9 months with SOC alone, with an HR of 0.45. Subgroup analyses further confirmed the consistent benefits of MDT across different patient groups. Regardless of factors like castration status, receipt of prior primary treatment, stage, or number of metastases, MDT consistently improved PFS. In patients with mHSPC, MDT significantly delayed the time to castration resistance by nine months, extending it to a median of 72 months compared to 63 months in the SOC group with an HR of 0.58. In terms of OS, the addition of MDT improved the 48-month survival rate by 12%, with OS rates of 87% in the MDT+SOC group compared to 75% in the SOC alone group. Dr. Neeraj Agarwal: Thank you, Peter. These data demonstrate that adding MDT to systemic therapy significantly improves PFS, rPFS, and castration resistance-free survival, reinforcing its potential role in the treatment of oligometastatic prostate cancer. So, let's switch gears to bladder cancer and start with Abstract 658 reporting the OS analysis of the CheckMate-274 trial. Would you like to tell us about this abstract?  Dr. Peter Hoskin: Yes, sure, Neeraj. This was presented by Dr. Matt Milowsky, and it was additional efficacy outcomes, including overall survival, from the CheckMate-274 trial which evaluated adjuvant nivolumab versus placebo in patients with high-risk muscle-invasive bladder cancer after radical surgery. The phase 3 trial previously demonstrated a significant improvement in disease-free survival with nivolumab. With a median follow-up of 36.1 months, disease-free survival was longer with nivolumab compared to placebo across all patients with muscle-invasive bladder cancer, reducing the risk of disease recurrence or death by 37%. Among patients who had received prior neoadjuvant cisplatin-based chemotherapy, nivolumab reduced this risk by 42%, whilst in those who had not received chemotherapy, the risk was reduced by 31%. Overall survival also favored nivolumab over placebo, reducing the risk of death by 30% in all patients with muscle-invasive bladder cancer and by 52% in those with tumors expressing PD-L1 at 1% or higher. Among patients who had received prior neoadjuvant chemotherapy, nivolumab reduced the risk of death by 26%, whilst in those who had not received chemotherapy, the risk was reduced by 33%. Alongside this, the safety profile remained consistent with previous findings. Dr. Neeraj Agarwal: Thank you, Peter, for such a nice overview of this abstract. These results reinforce adjuvant nivolumab as a standard of care for high-risk muscle-invasive bladder cancer, offering the potential for a curative outcome for our patients. Dr. Peter Hoskin: I agree with you Neeraj. Perhaps you would like to mention Abstract 659 titled, “Additional efficacy and safety outcomes and an exploratory analysis of the impact of pathological complete response (pCR) on long-term outcomes from NIAGARA.” Dr. Neeraj Agarwal: Of course. Dr. Galsky presented additional outcomes from the phase 3 NIAGARA study, which evaluated perioperative durvalumab combined with neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer. The study previously demonstrated a significant improvement in event-free survival and overall survival with durvalumab compared to chemotherapy alone, with a manageable safety profile and no negative impact on the ability to undergo radical cystectomy. Among the 1,063 randomized patients, those who received durvalumab had a 33% reduction in the risk of developing distant metastases or death and a 31% reduction in the risk of dying from bladder cancer compared to those who received chemotherapy alone. More patients who received durvalumab achieved a pathological complete response at the time of surgery with 37% compared to 28% in the chemotherapy-alone group. Patients who achieved a pathological complete response had better event-free survival and overall survival compared to those who did not. In both groups, durvalumab provided additional survival benefits, reducing the risk of disease progression or death by 42% and the risk of death by 28% in patients with a pathological complete response, while in those patients without a pathological complete response, the risk of disease progression or death was reduced by 23% and the risk of death by 16% when durvalumab was added to the chemotherapy. Immune-mediated adverse events occurred in 21% of patients in the durvalumab group compared to 3% in the chemotherapy-alone group, with grade 3 or higher events occurring in 3% compared to 0.2%. The most common immune-related adverse events included hypothyroidism in 10% of patients treated with durvalumab compared to 1% in the chemotherapy-alone group, and hyperthyroidism in 3% versus 0.8%. At the time of the data cutoff, these adverse events had resolved in 41% of affected patients in the durvalumab group and 44% in the chemotherapy-alone group. Dr. Peter Hoskin: Thank you, Neeraj, for the great summary. These findings further support the role of perioperative durvalumab as a potential standard of care for patients with muscle-invasive bladder cancer. Dr. Neeraj Agarwal: I concur with your thoughts, Peter. Before wrapping up the bladder cancer section, would you like to mention Abstract 664 reporting updated results from the EV-302 trial, which evaluated enfortumab vedotin in combination with pembrolizumab compared to chemotherapy as first-line treatment for patients with previously untreated locally advanced or metastatic urothelial carcinoma? Dr. Peter Hoskin: Yes, of course. Dr. Tom Powles presented updated findings from the EV-302 study, and in this abstract presented 12 months of additional follow-up for EV-302 (>2 y of median follow-up) and an exploratory analysis of patients with confirmed complete response (cCR). The study had a median follow-up of 29.1 months and previously demonstrated significant improvements in progression-free survival and overall survival with enfortumab vedotin and pembrolizumab. This is now the standard of care in global treatment guidelines. Among the 886 randomized patients, enfortumab vedotin and pembrolizumab reduced the risk of disease progression or death by 52% and the risk of death by 49% compared to chemotherapy. The survival benefit was consistent regardless of cisplatin eligibility or the presence of liver metastases. The confirmed objective response rate was higher with enfortumab vedotin and pembrolizumab at 67.5% compared to 44.2% with chemotherapy. The median duration of response was 23.3 months with enfortumab vedotin and pembrolizumab compared to 7.0 months with chemotherapy. A complete response was achieved in 30.4% of patients in the enfortumab vedotin and pembrolizumab group compared to 14.5% in the chemotherapy group, with the median duration of complete response not yet reached in the enfortumab vedotin and pembrolizumab group compared to 15.2 months in the chemotherapy group. Severe treatment-related adverse events occurred in 57.3% of patients treated with enfortumab vedotin and pembrolizumab compared to 69.5% in the chemotherapy group, while in patients who achieved a complete response, severe adverse events occurred in 61.7% of those treated with enfortumab vedotin and pembrolizumab compared to 71.9% with chemotherapy. Treatment-related deaths were reported in 1.1% of patients treated with enfortumab vedotin and pembrolizumab compared to 0.9% with chemotherapy, with no treatment-related deaths occurring in those who achieved a complete response. These findings clearly confirm the durable efficacy of enfortumab vedotin and pembrolizumab, reinforcing its role as the standard of care for the first-line treatment of patients with locally advanced or metastatic urothelial carcinoma, and no new safety concerns have been identified. Dr. Neeraj Agarwal: Thank you for this great summary. Moving on to kidney cancer, let's talk about Abstract 439 titled, “Nivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): Final follow-up results from the CheckMate-9ER trial.” Dr. Peter Hoskin: Sure. Dr. Motzer presented the final results from the phase 3 CheckMate-9ER trial, which compared the combination of cabozantinib and nivolumab against sunitinib in previously untreated advanced renal cell carcinoma. The data after more than five years follow-up show that the combination therapy provided sustained superior efficacy compared to sunitinib. In terms of overall survival, we see an 11-month improvement in median OS, 46.5 months for the cabo-nivo versus 35.5 months for sunitinib and a 42% reduction in the risk of disease progression or death, with median progression-free survival nearly doubling – that's 16.4 months in the combination group and 8.3 months with sunitinib. Importantly, the safety profile was consistent with the known safety profiles of the individual medicines, with no new safety concerns identified. Dr. Neeraj Agarwal: Great summary, Peter. These data further support the efficacy of cabo-nivo combination therapy in advanced renal cell carcinoma, which is showing a 11-month difference in overall survival. Dr. Peter Hoskin: Neeraj, before wrapping up this podcast, would you like to tell us about Abstract 618? This is titled “Prospective COTRIMS (Cologne trial of retroperitoneal lymphadenectomy in metastatic seminoma) trial: Final results.” Dr. Neeraj Agarwal: Sure, Peter. I would be delighted to. Dr Heidenrich from the University of Cologne in Germany presented the COTRIMS data evaluating retroperitoneal LN dissection in patients with clinical stage 2A/B seminomas. Seminomas are classified as 2A or B when the disease spreads to the retroperitoneal lymph nodes of up to 2 cm (CS IIA) or of more than 2 cm to up to 5 cm (CS 2B) in maximum diameter, respectively. They account for 10-15% of seminomas and they are usually treated with radiation and chemotherapy. However, radiation and chemo can be associated with long-term toxicities such as cardiovascular toxicities, diabetes, solid cancers, leukemia, particularly for younger patients. From this standpoint, Dr Heidenrich and colleagues evaluated unilateral, modified template, nerve-sparing retroperitoneal lymph node dissection as a less toxic alternative compared to chemo and radiation. They included 34 patients with negative AFP, beta-HCG, and clinical stage 2A/B seminomas. At a median follow-up of 43.2 months, the trial demonstrated great outcomes: a 99.3% treatment-free survival rate and 100% overall survival, with only four relapses. Antegrade ejaculation was preserved in 88% of patients, and severe complications such as grade 3 and 4 were observed in 12% of patients. Pathological analysis revealed metastatic seminoma in 85% of cases, with miR371 being true positive in 23 out of 24 cases and true negative in 100% of cases. It appears to be a valid biomarker for predicting the presence of lymph node metastases. These findings highlight retroperitoneal lymph node dissection is feasible; it has low morbidity, and excellent oncologic outcomes, avoiding overtreatment in 80% of patients and sparing unnecessary chemotherapy or radiotherapy in 10-15% of cases. Dr. Peter Hoskin: Great summary and important data on retroperitoneal lymphadenectomy in metastatic seminoma. These findings will help shape clinical practice. Any final remarks before we conclude today's podcast? Dr. Neeraj Agarwal: Before wrapping up this podcast, I would like to say that we have reviewed several abstracts addressing prostate, bladder, kidney cancers, and seminoma, which are impacting our medical practices now and in the near future. Peter, thank you for sharing your insights with us today. These updates are undoubtedly exciting for the entire GU oncology community, and we greatly appreciate your valuable contribution to the discussion and your leadership of the conference. Many thanks. Dr. Peter Hoskin: Thank you, Neeraj. Thank you for the opportunity to share this information more widely. I'm aware that whilst we have nearly 6,000 delegates, there are many other tens of thousands of colleagues around the world who need to have access to this information. And it was a great privilege to chair this ASCO GU25. So, thank you once again, Neeraj, for this opportunity to share more of this information that we discussed over those few days. Dr. Neeraj Agarwal: Thank you, Peter. And thank you to our listeners for joining us today. You will find links to the abstracts discussed today on the transcript of this episode. Finally, if you value the insights that you hear on the ASCO Daily News podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.  Find out more about today's speakers:   Dr. Neeraj Agarwal    @neerajaiims    Dr. Peter Hoskin Follow ASCO on social media:      @ASCO on Twitter      ASCO on Bluesky  ASCO on Facebook      ASCO on LinkedIn      Disclosures: Dr. Neeraj Agarwal: Consulting or Advisory Role: Pfizer, Bristol-Myers Squibb, AstraZeneca, Nektar, Lilly, Bayer, Pharmacyclics, Foundation Medicine, Astellas Pharma, Lilly, Exelixis, AstraZeneca, Pfizer, Merck, Novartis, Eisai, Seattle Genetics, EMD Serono, Janssen Oncology, AVEO, Calithera Biosciences, MEI Pharma, Genentech, Astellas Pharma, Foundation Medicine, and Gilead Sciences Research Funding (Institution): Bayer, Bristol-Myers Squibb, Takeda, Pfizer, Exelixis, Amgen, AstraZeneca, Calithera Biosciences, Celldex, Eisai, Genentech, Immunomedics, Janssen, Merck, Lilly, Nektar, ORIC Pharmaceuticals, Crispr Therapeutics, Arvinas Dr. Peter Hoskin: Research Funding (Institution): Varian Medical Systems, Astellas Pharma, Bayer, Roche, Pfizer, Elekta, Bristol Myers  

EPISODE SUMMARY: Effective communication and building trust are essential skills for child abuse professionals working towards a shared mission to protect children and support families. In this episode, Ken Homer discusses the concept of Collaborative Conversations, a four-step model designed to enhance communication, build trust, and foster meaningful teamwork. Children's Advocacy Center (CAC) staff and multidisciplinary team (MDT) partners can apply this practical approach to collaborate more effectively. Tune in for helpful tips to strengthen teamwork and achieve better outcomes for children and families. Topics in this episode: Collective Intelligence (4:26) Collaborative Conversations Wheel (7:25) Shared Meaning (9:00) Exploring Possibilities (19:38) Coordinating Actions (26:08) Learning and Reflecting (36:47) Communication Tips (44:02) Navigating Conflict (46:18) GUEST: Ken Homer, PCC Trained as an Integral Coach with a background that includes a decade on the core team that developed the World Café dialogue process, Ken works at the intersection of individual, team, and organizational learning to open up new vistas of thinking while finding practical steps for effective action. Grounded, insightful, practical, and comprehensive, are a few of the adjectives that Ken's clients have used to describe him. He listens deeply to gain an understanding and checks to see if he is making accurate assessments before attempting to provide any guidance. Ken looks for simple modest steps that can be sustained over time to provide optimal returns. Ken believes that collaboration is an art form based on learnable skills. “How can we be smarter together and work in ways where we are all enriched or even ennobled by our efforts?” is the question at the heart of Ken's work. He works with both individuals and teams to identify where they are not getting the results they desire and then helps them to develop the competencies required to achieve their aims. RECOMMENDED RESOURCES: Appreciative Inquiry: A Positive Revolution in Change by David L. Cooperride. And Diana Whitney, 2005: https://a.co/d/38PzqTi Collaborative Conversations: https://www.kenhomer.net Northeast Regional Children's Advocacy Center: https://www.nrcac.org Regional Children's Advocacy Centers: https://www.regionalcacs.org   Have an idea for a future Team Talk guest or topic? We want to hear from you! Click here to share your suggestions. Disclaimer: This project was sponsored by NRCAC from Grant Award Number 15PJDP-22-GK-03061-JJVO awarded by the Office of Juvenile Justice and Delinquency Prevention, Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the Department of Justice, OJJDP or NRCAC.  

In this episode, I share a story from when I was out at a bar with friends and unexpectedly began to channel the spirit of a loved one – my friend's mom, who had passed. While the connection was meaningful, I quickly realized the importance of keeping mediumship separate from alcohol or any substance that can cloud your energy. Tune in as I discuss why it's crucial to maintain a clear, grounded connection when channelling spirit and why drinking and mediumship should not mix.  If you're developing your own mediumship abilities, this episode is a must-listen-to ensure you approach spirit communication with the respect, clarity, and boundaries it deserves. Book with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on April 12 & 13: https://www.themediuminthemiddle.com/reiki-level-one Register for the Usui Reiki Level Two Course, March 8 & 9: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) February 27 @ 6 pm MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/

In this episode, we dive deep into how to get the most value from your Akashic Record reading. Whether you're new to the Akashic Records or you've had a few sessions, the key to an impactful reading lies in asking the right questions. I share practical tips on how to form both basic and in-depth questions to unlock the wisdom of your soul's journey. You'll learn how to approach your reading with clarity, how to dive deeper into your personal inquiries, and how to ensure that you leave with meaningful insights that empower your path. Tune in to get the most bang for your buck in your next Akashic Record session! Book with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on March 22 & 23 2025 (1 spot left!) : https://www.themediuminthemiddle.com/reiki-level-one Register for the Usui Reiki Level Two Course, March 8 & 9: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) February 27 @ 6 pm MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/ *Reminder I only have one Instagram account, and I will never DM you for money. All business is done on my website.

S&P Futures are trading slightly lower this morning with the pause in implementations of tariffs remaining the key headline. The key here is that it allows countries the opportunity to negotiate trade barriers ahead of any tariff action being implemented. Later this morning there are economic reports on Retail Sales and Industrial Production. ABNB, DKNG, FROG, GT, ROKU & WYNN are all higher after releasing their earnings reports. Monday is a holiday, on Tuesday morning watch for earnings from BIDU, FLR, GPC & MDT. The House Budget Committee passed a Budget Resolution and it will not go to the full House for a vote. Hong Kong markets surged as China's President is meeting with business leaders in an effort to expand growth. Oil prices are moving higher as tariff announcements are delayed.

The final part of the three-part psychic love story is here! Check-in with your intuition before this episode with three questions: do we go on a date? Do I see him again? Are we dating now? Tune in to find out how the date went with Mr. Jasper and where we are now. The biggest lesson from this series is to trust your intuition and the roads it leads you down!  Book with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on March 22 & 23 2025: https://www.themediuminthemiddle.com/reiki-level-one Register for the Usui Reiki Level Two Course, March 8 & 9: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on February 15 @ 11 am MDT, and February 27 @ 6 pm MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/ *Reminder I only have one Instagram account, and I will never DM you for money. All business is done on my website.

Part two of the psychic love story series introduces the psychic portion of the story. This episode shares about two very important dreams that I had that led me to find out information regarding Mr. Jasper and a second dream telling me to call him. I'm not going to call him, maybe I will send him a Facebook message. I can't message him again, the last time I messaged him was in 2017 saying I was dreaming about him. Do I message him? Tune in next week for the final part of the series!  Book with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course on March 22 & 23 2025: https://www.themediuminthemiddle.com/reiki-level-one Register for the Usui Reiki Level Two Course, March 8 & 9: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on February 15 @ 11 am MDT, and February 27 @ 6 pm MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/ *Reminder I only have one Instagram account, and I will never DM you for money. All business is done on my website.

In This Hour:SHOT Show 2025 from the Ruger booth.-- Thermal, night vision, and optics from Armasight and Winchester.-- SDS Imports brings in classic gun designs from Turkey.  -- MDT chassis stocks, mags, and so much more. Innovation for modern shooters.--  LuthAR gets into the rifle barrel business.Gun Talk 02.02.25 Hour 3 

Part one of a three-part psychic love story will be shared over the next three episodes. This episode starts in 2010, with the introduction of Mr. Jasper. Fast forward to 2018 when Mr. Jasper happened to walk into a restaurant in Banff on the same day Medium in the Middle took off her engagement ring from Joe. Follow along the journey to see how this all unfolds!  Book with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course, February 22 & 23 (1 spot left!) and March 22 & 23 2025: https://www.themediuminthemiddle.com/reiki-level-one Register for the Usui Reiki Level Two Course, March 8 & 9: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on February 15 @ 11 am MDT, and February 27 @ 6 pm MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/ *Reminder I only have one Instagram account, and I will never DM you for money. All business is done on my website.

The final part of the 3 part series around manifesting the house and all the details that went into it. It was not fast or easy, but all the signs from the universe led me home. This episode shares all the little and big details that perfectly aligned and all the synchronicities that occurred to make me confident in my decision to keep both houses and pull the trigger on moving forward. Before listening to this episode, listen to episodes 248 and 249, which share the first two parts of the house series. This last episode wraps up all the final details, which will hopefully help you in your manifestations.  Book with Medium in the Middle (Virtually or in-person in Banff): https://mediuminthemiddle.as.me/schedule.php Register for the next virtual Usui Reiki Level One Course, February 22 & 23, 2025: https://www.themediuminthemiddle.com/reiki-level-one Register for the Usui Reiki Level Two Course, March 8 & 9: https://www.themediuminthemiddle.com/reiki-level-two Sign up for the Practice Mediumship Circle (no experience necessary) on February 15 @ 11 am MDT, and February 27 @ 6 pm MDT: https://www.themediuminthemiddle.com/meeting-in-the-middle Follow along on social media: https://www.facebook.com/mediuminthemiddle/ https://www.instagram.com/mediuminthemiddle/ *Reminder I only have one Instagram account, and I will never DM you for money. All business is done on my website.